Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-307211
Filing Date
2020-12-01
Accepted
2020-12-01 16:42:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11756
  Complete submission text file 0001193125-20-307211.txt   12651
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations